皮肤库市场－全球产业规模、份额、趋势、机会和预测（2021-2031）

全球皮肤库市场预计将从 2025 年的 24.3 亿美元成长到 2031 年的 36.9 亿美元，复合年增长率为 7.21%。

皮肤库是专门从事人体皮肤同种异体移植片的采集、处理、保存和分发的医疗机构，这些移植片是治疗严重烧烫伤和大量组织缺损所必需的生物敷料。皮肤库的发展主要受烧烫伤病例增加和移植片保存技术进步的推动，这些进步延长了组织的存活时间。美国烧烫伤协会的数据凸显了这一迫切需求，报告显示，2024年全美114家中心共收治了32993例急性烧烫伤患者，这表明治疗复杂创伤病例对活性供体组织的持续需求。

儘管有这些市场驱动因素，但由于皮肤捐赠长期短缺，该市场仍面临许多障碍。这个问题主要源自于公众意识不足以及文化和宗教因素对遗体捐赠的顾虑。这种短缺造成了供需之间的巨大缺口，迫使医疗机构转向替代疗法，并限制了生物皮肤库服务的普及。因此，维持充足的同种异体移植皮肤库存十分困难，这仍然是该领域进一步扩张和发展的主要障碍。

市场驱动因素

烧烫伤和严重创伤发生率的不断上升是全球皮肤库市场的主要驱动力，迫切需要稳定的同种异体移植材料供应，用于急性伤口管理。严重烧烫伤通常会损伤大面积皮肤，因此必须即时使用生物敷料来预防感染、减少体液流失，并在永久性自体移植前促进伤口癒合。近期的损伤统计数据也印证了这种持续的需求。例如，在2025年10月，作为2025年全国烧烫伤意识日的一部分，儿童烧伤信託基金会宣布，根据国际烧烫伤损伤资料库的数据，2022年至2024年间，因严重热饮烧烫伤而入院接受专业烧烫伤护理的儿童患者人数增加了16.4%。创伤病例的增加直接给皮肤库维持充足组织库存的能力带来了压力。

同时，皮肤癌和黑色素瘤的发病率上升也显着推动了市场成长。外科治疗通常需要大范围切除组织，因此需要进行植皮重组。恶性肿瘤发生率的上升推动了切除后重组治疗方法的需求，并促进了自体皮肤和先进组织替代技术的应用。根据美国癌症协会于2025年1月发布的《2025年癌症事实与数据》报告，预计2025年美国将新增约104,960例黑色素瘤病例，凸显了需要进行皮肤手术的患者群体不断扩大。临床需求的快速成长也反映在主要产业参与者的财务表现。 2025年2月，Vericel公司报告称，其2024年全年与烧烫伤治疗相关的收入净额增长了22%，达到3990万美元，表明皮肤修復行业拥有强劲的商业性发展势头。

市场挑战

全球皮肤库市场成长面临的一大瓶颈是皮肤捐赠的持续短缺。这种短缺造成了供需之间的持续缺口，皮肤库往往难以维持足够的同种异体移植片库存，以满足大规模创伤治疗的需求。当生物皮肤供应无法满足烧烫伤科室的即时临床需求时，医疗机构被迫转向合成替代物和异质骨移植。这种对替代疗法的依赖限制了人类皮肤库服务的广泛应用，并对从事同种异体移植片处理和储存的机构的盈利能力产生了负面影响。

创伤性损伤的高发生率进一步加剧了组织短缺的影响。例如，儿童烧伤信託基金会报告称，2024年有9,244名儿童遭受烧烫伤或烫伤。如此庞大的数字，仅仅代表一个人口群体，凸显了组织供应的巨大压力。由于捐献率无法跟上此类损伤的高发生率，市场难以有效扩大规模。缺乏可靠的可用组织供应削弱了人们对生物银行系统的信心，并阻碍了整个领域的发展。

市场趋势

为了克服供应不稳定的问题，寻求传统尸体异体移植替代方案的捐赠者正转向混合型和生物工程皮肤产品，这从根本上重塑了市场格局。这项转变的驱动力在于先进的细胞技术和合成基质，它们能够提高伤口缝合率并降低排斥风险，从而有效克服捐赠者供应的限制。这些生物工程解决方案因其在慢性伤口和烧烫伤治疗中提供的即用型便利性而获得商业性认可，减少了对不可预测的生物库存的依赖。这项商业性进展在主要企业的业绩中得到了体现。 Integra Lifesciences公司在2025年2月发布的「2024财年第四季及全年业绩」中报告称，总收入达16.1亿美元，凸显了儘管面临营运挑战，但其再生组织产品组合的需求依然强劲。

同时，微创微移植技术的广泛应用正在革新烧烫伤治疗，显着减少了治疗大面积烧伤所需的供皮量。这些系统利用自体细胞采集技术生产移植片，其覆盖的创面面积远大于供皮区，从而减轻患者的身体负担并促进上皮化。这项技术直接解决了供皮供不应求这一严峻挑战，并正迅速成为烧伤治疗的标准疗法。为了佐证这一趋势，Avita Medical在2025年2月发布的2024财年第四季及全年财务报告中宣布，由于其RECELL系统在创伤中心的广泛应用，公司实现了6400万美元的商业收入（同比增长29%）。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球皮肤库市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依皮肤移植类型（自体移植与异体移植）
  • 依应用领域（烧烫伤患者、整形外科创伤患者、难癒合溃疡、压疮等）
  • 依所有权类型（公有、私有、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美皮肤库市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲皮肤库市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区皮肤库市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲皮肤库市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲皮肤库市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球皮肤库市场：SWOT分析

第十四章 波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• National Burns Centre
• Yorkshire Regional Tissue Bank
• Dutch National Skin Bank
• Euro Skin Bank
• Evangelical University Hospital of Curitiba（HUEC）Skin Bank
• Ganga Hospital Skin Bank
• Singapore General Hospital（SGH）Skin Bank
• New York Firefighters Skin Bank
• Helsinki Skin Bank
• OGH Skin Bank

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Skin Bank Market is projected to expand from USD 2.43 Billion in 2025 to USD 3.69 Billion by 2031, registering a CAGR of 7.21%. Skin banks function as specialized medical facilities focused on the harvesting, processing, preservation, and distribution of human skin allografts, which are crucial biological dressings for managing severe burns and significant tissue loss. This growth is primarily driven by the increasing frequency of burn injuries alongside advancements in graft preservation technologies that prolong tissue viability. Data from the American Burn Association highlights this urgent need, reporting 32,993 acute burn admissions across 114 centers in 2024, emphasizing the continuous demand for viable donor tissue to treat complex trauma cases.

Despite these drivers, the market faces significant hurdles due to a chronic shortage of skin donations, a problem largely attributed to limited public awareness and cultural or religious reservations concerning post-mortem donation. This scarcity results in a considerable gap between supply and demand, compelling healthcare providers to depend on alternative treatments and restricting the broad availability of biological skin banking services. Consequently, the difficulty in maintaining sufficient allograft inventories persists as a major barrier to the further expansion and development of this sector.

Market Driver

The growing incidence of burn injuries and severe trauma serves as a major driver for the global skin bank market, creating an urgent need for a steady supply of allografts for acute wound management. Because severe burns frequently damage extensive skin surface areas, immediate biological dressings are essential to halt infection, minimize fluid loss, and expedite healing prior to permanent autografting. This sustained demand is underscored by recent injury statistics; for example, the Children's Burns Trust announced in October 2025, as part of 'National Burn Awareness Day 2025', that data from the International Burn Injury Database indicated a 16.4% increase in children admitted to specialist burns services for severe hot drink burns between 2022 and 2024. Such increases in trauma cases directly heighten the pressure on skin banks to secure sufficient tissue stocks.

In parallel, the rising prevalence of skin cancer and melanoma is substantially fueling market growth, as surgical treatments often require extensive tissue removal necessitating grafts for reconstruction. As malignancy rates increase, the demand for post-excision reconstructive options drives the use of banked skin and advanced substitutes. According to the 'Cancer Facts & Figures 2025' report released by the American Cancer Society in January 2025, approximately 104,960 new melanoma cases were projected in the United States for the year, highlighting the expanding patient population requiring dermatological surgery. This surge in clinical need is mirrored in the financial results of major sector participants; Vericel Corporation reported in February 2025 that its burn care net revenue grew by 22% to $39.9 million for the full year 2024, indicating strong commercial momentum within the skin repair industry.

Market Challenge

A critical bottleneck restricting the growth of the Global Skin Bank Market is the persistent shortage of skin donations. This scarcity generates a continuous gap between supply and demand, as skin banks often struggle to keep adequate inventories of the allografts needed for treating widespread trauma. When the supply of biological skin falls short of the immediate clinical requirements of burn units, medical providers are forced to rely on synthetic substitutes or xenografts. Such dependence on alternative therapies constrains the broader adoption of human skin banking services and negatively impacts the revenue potential for facilities engaged in allograft processing and storage.

The consequences of this shortage are further amplified by the high volume of trauma cases necessitating intervention. For instance, the Children's Burns Trust reported that 9,244 children suffered burns or scalds in 2024. This significant number, representing just one demographic segment, underscores the immense strain placed on available tissue supplies. Since the rate of donation fails to align with the high frequency of these injuries, the market faces difficulties in scaling operations efficiently. The inability to ensure a reliable supply of viable tissue ultimately weakens confidence in bio-banking systems and impedes the overall advancement of the sector.

Market Trends

The market is being fundamentally reshaped by a transition toward hybrid and bio-engineered skin products as providers look for alternatives to traditional cadaveric allografts to overcome supply inconsistencies. This shift is powered by advanced cellular and synthetic matrices that deliver improved wound closure rates and lower rejection risks, effectively countering the limitations of donor availability. These bio-engineered solutions are securing commercial traction by offering off-the-shelf convenience for the treatment of chronic wounds and burns, which reduces dependence on unpredictable biological inventories. This commercial progress is evident in the performance of major industry players; Integra LifeSciences reported total revenues of $1.61 billion in its 'Fourth Quarter and Full-Year 2024 Financial Results' in February 2025, highlighting the strong demand for its regenerative tissue portfolio despite operational hurdles.

Concurrently, the uptake of minimally invasive micro-grafting technologies is revolutionizing burn care by significantly decreasing the amount of donor skin needed to treat extensive injuries. These systems employ autologous cell harvesting to generate grafts that cover wound areas much larger than the donor site, thereby reducing patient trauma and hastening epithelialization. This technology directly tackles the critical challenge of limited donor skin availability and is quickly emerging as a standard of care for thermal burn management. Underscoring this trend, Avita Medical announced in February 2025, within its 'Fourth Quarter and Full Year 2024 Financial Results', that it achieved commercial revenue of $64.0 million, a 29% increase attributed to the growing use of its RECELL system in trauma centers.

Key Market Players

• National Burns Centre
• Yorkshire Regional Tissue Bank
• Dutch National Skin Bank
• Euro Skin Bank
• Evangelical University Hospital of Curitiba (HUEC) Skin Bank
• Ganga Hospital Skin Bank
• Singapore General Hospital (SGH) Skin Bank
• New York Firefighters Skin Bank
• Helsinki Skin Bank
• OGH Skin Bank

Report Scope

In this report, the Global Skin Bank Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Skin Bank Market, By Skin Graft

• Autograft v/s Allograft

Skin Bank Market, By Application

• Burns patient
• Orthopedic Trauma patients
• Non-Healing Ulcers
• Pressure-Source
• Others

Skin Bank Market, By Ownership

• Public
• Private
• Others

Skin Bank Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Skin Bank Market.

Available Customizations:

Global Skin Bank Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Skin Bank Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Skin Graft (Autograft v/s Allograft)
  • 5.2.2. By Application (Burns patient, Orthopedic Trauma patients, Non-Healing Ulcers, Pressure-Source, Others)
  • 5.2.3. By Ownership (Public, Private, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Skin Bank Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Skin Graft
  • 6.2.2. By Application
  • 6.2.3. By Ownership
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Skin Bank Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Skin Graft
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Ownership
  • 6.3.2. Canada Skin Bank Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Skin Graft
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Ownership
  • 6.3.3. Mexico Skin Bank Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Skin Graft
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Ownership

7. Europe Skin Bank Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Skin Graft
  • 7.2.2. By Application
  • 7.2.3. By Ownership
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Skin Bank Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Skin Graft
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Ownership
  • 7.3.2. France Skin Bank Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Skin Graft
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Ownership
  • 7.3.3. United Kingdom Skin Bank Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Skin Graft
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Ownership
  • 7.3.4. Italy Skin Bank Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Skin Graft
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Ownership
  • 7.3.5. Spain Skin Bank Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Skin Graft
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Ownership

8. Asia Pacific Skin Bank Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Skin Graft
  • 8.2.2. By Application
  • 8.2.3. By Ownership
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Skin Bank Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Skin Graft
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Ownership
  • 8.3.2. India Skin Bank Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Skin Graft
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Ownership
  • 8.3.3. Japan Skin Bank Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Skin Graft
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Ownership
  • 8.3.4. South Korea Skin Bank Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Skin Graft
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Ownership
  • 8.3.5. Australia Skin Bank Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Skin Graft
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Ownership

9. Middle East & Africa Skin Bank Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Skin Graft
  • 9.2.2. By Application
  • 9.2.3. By Ownership
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Skin Bank Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Skin Graft
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Ownership
  • 9.3.2. UAE Skin Bank Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Skin Graft
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Ownership
  • 9.3.3. South Africa Skin Bank Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Skin Graft
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Ownership

10. South America Skin Bank Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Skin Graft
  • 10.2.2. By Application
  • 10.2.3. By Ownership
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Skin Bank Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Skin Graft
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Ownership
  • 10.3.2. Colombia Skin Bank Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Skin Graft
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Ownership
  • 10.3.3. Argentina Skin Bank Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Skin Graft
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Ownership

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Skin Bank Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. National Burns Centre
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Yorkshire Regional Tissue Bank
• 15.3. Dutch National Skin Bank
• 15.4. Euro Skin Bank
• 15.5. Evangelical University Hospital of Curitiba (HUEC) Skin Bank
• 15.6. Ganga Hospital Skin Bank
• 15.7. Singapore General Hospital (SGH) Skin Bank
• 15.8. New York Firefighters Skin Bank
• 15.9. Helsinki Skin Bank
• 15.10. OGH Skin Bank

16. Strategic Recommendations

17. About Us & Disclaimer